NFG
CLVS

Norris Financial Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Norris Financial Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,516
Closed -$26.8K – 81
2022
Q3 		$26.8K Sell
22,516
-495
-2% -$772 0.02% 65
2022
Q2 		$41.4K Buy
23,011
+2,065
+10% +$3.05K 0.03% 64
2022
Q1 		$42.3K Sell
20,946
-880
-4% -$1.73K 0.03% 82
2021
Q4 		$59.1K Sell
21,826
-8,551
-28% -$31.6K 0.04% 83
2021
Q3 		$135K Buy
30,377
+7,553
+33% +$36.4K 0.09% 80
2021
Q2 		$132K Buy
22,824
+9,751
+75% +$57.1K 0.09% 80
2021
Q1 		$91.8K Buy
+13,073
New +$87.7K 0.07% 76
2020
Q3 		– Sell
-13,048
Closed -$88.1K – 88
2020
Q2 		$88.1K Sell
13,048
-2,412
-16% -$18.3K 0.08% 60
2020
Q1 		$98.3K Buy
+15,460
New +$124K 0.11% 58

Other funds holding CLVS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
CAS
Coppell Advisory Solutions Coppell, Texas $1.21B AUM 20.39% 1-Year Est. Return
CASC
Coppell Advisory Solutions Corp Coppell, Texas $531M AUM
STB
S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
FFWM
Future Financial Wealth Management Cincinnati, Ohio $160M AUM 21.24% 1-Year Est. Return
NFSG
Newbridge Financial Services Group Boca Raton, Florida $808M AUM 51.1% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Norris Financial Group's CLVS Position: Q4 2022 in Review

Norris Financial Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2022, closing a stake of 22,516 shares — an estimated $26.8K sold.

Norris Financial Group first reported a position in CLVS in Q1 2020 and held it in 9 quarters. The position peaked at $135K in Q3 2021. 15 funds tracked by Wall St. Rank hold CLVS as of Q4 2022.

  • Norris Financial Group reported no remaining Clovis Oncology, Inc. position as of Q4 2022 after selling out during the quarter.
  • Norris Financial Group sold 22,516 Clovis Oncology, Inc. shares in Q4 2022, an estimated $26.8K.
  • Norris Financial Group first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 9 quarters.
  • Norris Financial Group's Clovis Oncology, Inc. position peaked at $135K in Q3 2021.
  • 15 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2022.

Based on Norris Financial Group's 13F filing for Q4 2022, filed 20 May 2026.